This protocol is judged by an institutional critique board, an unbiased group that reviews any clinical trials involving individuals. If a research consists of a Plan I drug, as soon as the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) variety within the FDA.He stated he appr